241 related articles for article (PubMed ID: 22343334)
41. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
42. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R
Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904
[TBL] [Abstract][Full Text] [Related]
43. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
[TBL] [Abstract][Full Text] [Related]
44. The use of Campath-1H as induction therapy in renal transplantation: preliminary results.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roohipour R; Carreno MR; Roth D; Ruiz P; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J
Transplantation; 2004 Aug; 78(3):426-33. PubMed ID: 15316372
[TBL] [Abstract][Full Text] [Related]
45. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
Welberry Smith MP; Cherukuri A; Newstead CG; Lewington AJ; Ahmad N; Menon K; Pollard SG; Prasad P; Tibble S; Giddings E; Baker RJ
Transplantation; 2013 Dec; 96(12):1082-8. PubMed ID: 24056618
[TBL] [Abstract][Full Text] [Related]
46. Increased numbers of circulating CD8 effector memory T cells before transplantation enhance the risk of acute rejection in lung transplant recipients.
San Segundo D; Ballesteros MÁ; Naranjo S; Zurbano F; Miñambres E; López-Hoyos M
PLoS One; 2013; 8(11):e80601. PubMed ID: 24236187
[TBL] [Abstract][Full Text] [Related]
47. Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants.
Jones DL; Sacks SH; Wong W
Transplantation; 2006 Nov; 82(10):1352-61. PubMed ID: 17130785
[TBL] [Abstract][Full Text] [Related]
48. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
Morelon E; Lefrançois N; Besson C; Prévautel J; Brunet M; Touraine JL; Badet L; Touraine-Moulin F; Thaunat O; Malcus C
Transpl Immunol; 2010 May; 23(1-2):53-8. PubMed ID: 20406686
[TBL] [Abstract][Full Text] [Related]
49. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
Mittal SK; Sharma RK; Gupta A; Naik S
Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
[TBL] [Abstract][Full Text] [Related]
50. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
51. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
52. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
[TBL] [Abstract][Full Text] [Related]
53. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.
Kreijveld E; Koenen HJ; van Cranenbroek B; van Rijssen E; Joosten I; Hilbrands LB
PLoS One; 2008 Jul; 3(7):e2711. PubMed ID: 18628993
[TBL] [Abstract][Full Text] [Related]
54. Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro.
Podestà MA; Binder C; Sellberg F; DeWolf S; Shonts B; Ho SH; Obradovic A; Waffarn E; Danzl N; Berglund D; Sykes M
Am J Transplant; 2020 Jan; 20(1):88-100. PubMed ID: 31319439
[TBL] [Abstract][Full Text] [Related]
55. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
56. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
Nainani N; Patel N; Tahir N; Kumar R; Weber-Shrikant E; Gundroo AA; Murray BM; Tornatore KM; Blessios GA; Venuto RC
Nephrol Dial Transplant; 2012 May; 27(5):2077-83. PubMed ID: 22058172
[TBL] [Abstract][Full Text] [Related]
57. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
[TBL] [Abstract][Full Text] [Related]
58. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
[TBL] [Abstract][Full Text] [Related]
59. Immune profile of pediatric renal transplant recipients following alemtuzumab induction.
De Serres SA; Mfarrej BG; Magee CN; Benitez F; Ashoor I; Sayegh MH; Harmon WE; Najafian N
J Am Soc Nephrol; 2012 Jan; 23(1):174-82. PubMed ID: 22052056
[TBL] [Abstract][Full Text] [Related]
60. Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation.
Zhou H; Lin J; Chen S; Ma L; Qiu Z; Chen W; Zhang X; Zhang Y; Lin X
Clin Exp Nephrol; 2013 Apr; 17(2):304-9. PubMed ID: 23053591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
